Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity Insider News Commentary - Routine medical ...

Century Therapeutics to host a fireside chat on April 22, discussing iPSC-derived cell therapy programs in autoimmune diseases and cancer. Century Therapeutics, Inc., a biotechnology company ...

Century Therapeutics, Inc. (NASDAQ: IPSC) announced that its management team will host a live fireside chat on Tuesday, April ...

Design Therapeutics (DSGN) announced the appointment of Chris Storgard, M.D., as Chief Medical Officer. Most recently, Dr. Storgard served as ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Urogen Pharma (URGN – Research Report) and ...

American Century Companies Inc. grew its position in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) by 12.4% in the 4th quarter, Holdings Channel reports.The institutional investor owned ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /CNW/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Feldan ...

Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornithine) for the treatment of adults and paediatric patients ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

Forecasts show cancer's global footprint expanding sharply, with annual case counts expected to rise 20% by 2030 and swell by ...